200,000+ products from a single source!
sales@angenechem.com
Home > Sulfanilamide > 86029-46-1
86029-46-1 | 1,3,4-Thiadiazole-2-sulfonamide, 4,5-dihydro-5-imino-4-methyl-
CAS No: 86029-46-1 Catalog No: AG004PFR MDL No:
Product Description
Catalog Number:
AG004PFR
Chemical Name:
1,3,4-Thiadiazole-2-sulfonamide, 4,5-dihydro-5-imino-4-methyl-
CAS Number:
86029-46-1
Molecular Formula:
C3H6N4O2S2
Molecular Weight:
194.2353
IUPAC Name:
5-imino-4-methyl-1,3,4-thiadiazole-2-sulfonamide
InChI:
InChI=1S/C3H6N4O2S2/c1-7-2(4)10-3(6-7)11(5,8)9/h4H,1H3,(H2,5,8,9)
InChI Key:
BWSMJWLWXNCHHP-UHFFFAOYSA-N
SMILES:
N=c1sc(nn1C)S(=O)(=O)N
Properties
Complexity:
313
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
193.993g/mol
Formal Charge:
0
Heavy Atom Count:
11
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
194.227g/mol
Monoisotopic Mass:
193.993g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
133A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2
Literature
| Title | Journal |
|---|---|
| Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. | Journal of medicinal chemistry 20120412 |
| Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana. | Bioorganic & medicinal chemistry 20120215 |
| Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. | Bioorganic & medicinal chemistry 20110815 |
| A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. | Bioorganic & medicinal chemistry 20110201 |
| Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. | Bioorganic & medicinal chemistry letters 20110115 |
| Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. | Journal of medicinal chemistry 20100311 |
| Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. | Bioorganic & medicinal chemistry letters 20091201 |
| Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. | Bioorganic & medicinal chemistry 20090715 |
| Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides. | Bioorganic & medicinal chemistry 20090701 |
| Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. | Journal of medicinal chemistry 20090514 |
| Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. | Journal of medicinal chemistry 20090423 |
| Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. | Bioorganic & medicinal chemistry 20090201 |
| Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. | Bioorganic & medicinal chemistry 20071201 |
| Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. | Bioorganic & medicinal chemistry letters 20070701 |
| Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. | Journal of medicinal chemistry 20070125 |
| Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. | Bioorganic & medicinal chemistry letters 20060415 |
| QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach. | Bioorganic & medicinal chemistry letters 20060401 |
| Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. | Journal of medicinal chemistry 20060323 |
| Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. | Journal of medicinal chemistry 20051201 |
| Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. | Bioorganic & medicinal chemistry letters 20050901 |
| Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? | Bioorganic & medicinal chemistry letters 20050215 |
| Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20050215 |
| Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20040621 |
| Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20030324 |
| Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. | Journal of medicinal chemistry 20020328 |
| Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties. | Bioorganic & medicinal chemistry letters 20010226 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.